0.9465USD-0.32%Mkt Cap: 39.77M $P/E: —1d ago
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/B
Cheaper
1M Perf
Higher
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$3.03BUSDP/E 18.5
$54.86MUSD
ELXR
Elixxer Ltd.$9.51MUSD
CELG-RI
Bristol-Myers Squibb Company Ce—
PHOO
Photocure ASA—
ROSE
DocMorris AG—
FLXN
Horizon Flexible Income ETF—P/E 27.2
Indicators:|
Key Statistics
Company
Market Cap39.77M $
Enterprise Value30.37M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.44M $
Revenue/Share—
Last Price0.9465 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.31
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B4.26
EPS (TTM)-1.27
EPS (Forward)-0.41
52W Range
0.90003% of range2.450
52W High2.450 USD
52W Low0.9000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-100.49%
ROA-94.13%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.66M $
CapEx (TTM)—
FCF Margin—
FCF Yield-1.08%
Net Debt-9.41M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio82.16
Quick Ratio81.97
Book Value/Sh0.2220 USD
Cash/Share0.2240 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.02M
Float35.03M
Insiders16.71%
Institutions5.03%
Short Interest
Short Ratio2.1d
Short % Float0.71%
Short % Out.0.65%
Shares Short275.05K
Short (prev mo.)408.16K
Technical
SMA 501.005 (-5.8%)
SMA 2001.256 (-24.6%)
Beta1.44
S&P 52W Chg20.05%
Avg Vol (30d)112.27K
Avg Vol (10d)98.14K
Technical Indicators
RSI (14)46.2
MACD-0.0174
MACD Signal-0.0183
MACD Hist.+0.0009
BB Upper1.046 USD
BB Middle0.9695 USD
BB Lower0.8927 USD
BB Width15.83%
ATR (14)0.0531 USD
Vol Ratio (20d)0.35x